D
espite the advances in perinatal and neonatal care and use of newer potent antibiotics, the incidence of neonatal sepsis remains high, and the outcome is still severe. 1 Immature immunologic defenses in newborn infants, including low circulating levels of immunoglobulins, decrease in absolute number of T lymphocytes and neutrophils and functionally impaired cytotoxic activity in leukocytes, 2 which are important risk factors that predispose these infants to lifethreatening sepsis. The isolation of microorganisms from blood, cerebrospinal fluid, or urine remains the criterion standard for definitive diagnosis; however, confirmation or exclusion of positive cultures requires days, and more importantly, the sensitivity of the culture methods is frequently low, because of the concomitant antibiotic therapy or the combination of small blood sample volume and low colony counts. 3 In addition, in neonates, the clinical signs of sepsis are poor, late, and nonspecific, particularly in preterm infants, in whom the onset of sepsis may be acute, and clinical course can quickly deteriorate. Therefore, early diagnosis of a life-threatening disease such as neonatal sepsis is the mandatory prerequisite for a timely treatment. 4 CD64, a high-affinity receptor, is usually expressed at a low concentration on the surface of nonactivated neutrophils in preterm and term infants. 5 Upon antigenic challenge by microbial products, its expression will be substantially up-regulated. 6 CD64 is a high-affinity and restricted isotype-specificity FcFRI receptor expressed on macrophages, monocytes, neutrophils, and eosinophils. 7, 8 There are several reports regarding its potential utility for the diagnostic assessment of sepsis or infection in adults 9 and neonates. 10, 11 This prospective study aimed (1) to determine the diagnostic utilities (sensitivity, specificity, positive predictive value [PPV] , and negative predictive value [NPV]) of CD64, in comparison with conventional biochemical markers for diagnosing infection in term and preterm newborns and (2) to define the optimal cutoff value for neutrophil CD64 using the receiver operating characteristic (ROC) curve so that it may be used as a reference with which future studies can be compared.
PATIENTS AND METHODS

Patients
This prospective study included 75 neonates (40 preterm and 35 full term) born and admitted to the neonatal intensive care unit (NICU) of Kasr Al-Aini, Cairo University Hospital, over a period of 6 months. It is a tertiary unit, admitting neonates inborn in obstetric unit of the same hospital; the number of deliveries reaches 1000 to 1500/month, and the total NICU admission through the study period was 350 babies with an average of 50 newborns per month. Approval of Research Committee of Pediatrics Unit, Cairo University, was obtained. Data confidentiality was preserved according to the Revised Helsinki Declaration of Bioethics. 12 Subjects were classified into 1 of the following 3 groups:
1. first group: culture-proven sepsis (n = 25): neonates with sepsis proven by positive bacterial culture with the presence of 2 or more clinical symptoms or signs as below 2. second group: clinical sepsis (n = 25): neonates with sepsis with negative bacterial culture but with the presence of 2 or more clinical symptoms or signs of infection as below 3. control group (n = 25): newborns with no symptoms or signs of infection, but who took blood samples drawn because of suspicion of different diseases with normal findings and no illness subsequently detected
Clinical Manifestations of Sepsis
Two or more of the following clinical manifestations were used to determine patients for sepsis evaluations: (1) respiratory compromise: respiratory rate of more than 60 breaths per minute, or cessation of respiration for 20 seconds or more, occurring at a rate of 2 or more times per hour, or pulse oximeter readings of 85% or less; (2) cardiovascular compromise: heart rate of less than 100 beats per minute, pallor, or hypotension; (3) metabolic changes: hypothermia (rectal temperature of G36-C), body temperature of greater than 38-C, feeding intolerance (increased gastric residuals of 950% of milk volume in Q2 feedings within 24 hours), glucose instability (blood glucose level of G45 or 9125 mg/dL), or metabolic acidosis (pH G7.25); or (4) neurological changes: lethargy or decreased activity. 13 
Methods
Blood Samples
Blood was drawn and collected in 2 EDTA-containing vacutainers for a complete blood count, including manual differential and CD64 expression. Hematologic indices were measured on an automated cell counter (Sysmex K-1000, Kobe, Japan). Peripheral blood smear examination was done using standard techniques. Serum sample was obtained for C-reactive protein (CRP).
Blood Culture Processing
The Bactec 9050 fluorescent instrument (Becton-Dickinson, Franklin Lakes, NJ) was used to detect positive blood cultures. This is a closed system that uses a chemical sensor to detect increases in carbon dioxide production produced by the growth of microorganisms. The sensor is automatically monitored every 10 minutes for increased fluorescence, which is proportional to the amount of carbon dioxide produced by viable microorganisms in the vials that enables the instrument to determine positive vials (positive blood culture).
Avolume of 1 to 2 mL blood was added per blood culture bottle using the pediatric sampleYsized blood culture bottles (Peds Plus; Becton-Dickinson Infants whose culture results were positive were diagnosed as having confirmed sepsis. 
CD64 Expression by Flow Cytometry
CD64 expression on neutrophils was measured by staining 100 HL of whole blood with anti-CD64Yfluorescein isothiocyanate (provided by Beckman Coulters, Marseille, France) for 20 minutes in the dark. This was followed by lysis of the red blood cells, no washing, and an additional 10-minute incubation to allow equilibration and reduction of nonspecific background staining. The specimens were analyzed on a Beckman Coulter Epics XL flow cytometer.
Polymorphonuclear leukocytes were electronically selected on the basis of their side-and forward-scatter characteristics, and 10,000 cells were analyzed in each sample. Results were expressed as the percentage of positive cells and/or the mean fluorescence intensity.
C-Reactive Protein Detection in Human Serum
Slide agglutination method was done for the qualitative detection of CRP in human serum. Latex particles coated with goat immunoglobulin G antiYhuman CRP are agglutinated when mixed with samples containing CRP.
Statistical Methods
Data management and analysis were performed using Statistical Analysis Systems version 8.02 (Stat-Ease, Inc., Minneapolis, MN) and Statistical Package for Social Sciences version 17 (SPSS Inc., Chicago, IL). Comparisons between the 3 groups were done using the Kruskal-Wallis nonparametric test. Pairwise comparisons between the groups were performed using the Bonferroni adjustments. The ROC curve was used to calculate the area under the curve (AUC) as well as the sensitivity, specificity, PPV, and NPVof each measurement.
14 All P values were 2-sided. P G 0.05 was considered significant.
RESULTS
Seventy-five neonates were enrolled in the study and classified into 3 groups: demographic data of each group are presented in Table 1 . Blood cultures were positive in all cases of the first group (group of confirmed sepsis); culture growth results showed that each of Escherichia coli and Klebsiella pneumoniae were isolated from 5 cases; each of methicillinresistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Acinetobacter were isolated from 3 cases; methicillin-sensitive S. aureus were isolated from 2 cases; each of coagulase-negative Staphylococcus and Enterobacter were isolated from only 1 case, and 2 cases had mixed infection P. aeruginosa with either coagulase-negative Staphylococcus or K. pneumoniae.
Hematologic profiles including hemoglobin concentration and packed cell volume were not different among the 3 groups (Table 1) . On the contrary, white blood cell (WBC) count, band percentage, absolute band count (ABC), and absolute neutrophilic count (ANC) were significantly higher in confirmed and clinical sepsis groups compared with the control group ( Table 1) .
As regards segmented neutrophils percentage and I/T (immature to total neutrophil) ratio, a statistically significant difference was found where values were higher in the confirmed sepsis group compared with clinical sepsis and control groups. Platelet count was significantly lower in confirmed sepsis group when compared with the clinical sepsis group; in both groups, platelets are significantly lower than those in healthy controls (overall P G 0.001) ( Table 1) .
Neutrophil CD64 expression was increased significantly in the confirmed and clinical sepsis groups compared with the control group (P G 0.001). Mean fluorescence intensity did not differ among the 3 groups (Table 1) . Tables 2 and 3 show the AUC, sensitivity, specificity, PPV, and NPVof neutrophil CD64 and other hematologic parameters in confirmed and clinical sepsis groups using the best cutoff value. CD64 had a sensitivity of 96%, a specificity of 100%, a PPVof 96.2%, and an NPV of 100% with a cutoff value of 45.8% and 46.0%in the confirmed and the clinical clinical sepsis groups, respectively.
Receiver operating characteristic curve analysis of CD64 and other hematologic parameters such as WBC count, platelet count, ABC, ANC, and I/T ratio was performed. Figures 1 and 2 demonstrate comparisons of AUC from ROC curve analyses of CD64 and other hematologic parameters in confirmed and clinical sepsis groups, respectively. Table 4 demonstrates the AUC of a combination of CD64 / WBC, CD64/platelet count; CD64/ABC, and CD64/ANC. Combined CD64 and ABC had the highest AUC in both confirmed and clinical sepsis groups.
DISCUSSION
Neonatal sepsis continues to be one of the major contributors of neonatal morbidity and mortality. It needs to be diagnosed as early as possible for appropriate timely management. However, lack of specific clinical signs means that many other neonatal problems may be mistaken for septicemia, leading to unnecessary overuse of antibiotics. But this should not undermine the fact that the standard clinical practice is initiation of antibiotics after obtaining the cultures if infection is strongly suspected. 15 Although blood culturing is considered the criterion standard for diagnosis of neonatal bacterial sepsis and accurate identification of the bacterial isolates, 16 blood culturing technique is difficult, is time consuming (isolation of causative organism from blood culture takes up to 72 hours), 17 and has unacceptable low sensitivity due to intermittent seeding of low numbers of bacteria within the bloodstream, extremely small blood volume obtained from the infant for culturing, and use of intrapartum antibiotics to mothers of high risk. 18 Many efforts have focused on the use of hematologic parameters to increase the diagnostic yield for neonatal sepsis.
The readily achievable complete blood count and leukocyte differential assays have relatively poor specificity for diagnosing sepsis. The associated band count and leftward shift of myeloid immaturity measurements may improve diagnostic yield, but their subjective measurement is problematic. Therefore, the need persists for improved diagnostic indicators of neonatal sepsis. 19 Acute-phase reactants (eg, procalcitonin and C-reactive protein) have also been studied as markers of neonatal sepsis. 20 Unfortunately, because these acute-phase reactants have similar diagnostic properties, no single marker has been found to have a significant advantage over the others. The role of cytokines as a diagnostic aid in neonatal sepsis has been reviewed. 21 Despite the fact that a majority of the cytokine markers have high NPVs (ie, good for ruling out sepsis), these have not been adopted for general medical use. This is partly attributable to the larger amounts of blood required, the long interval to cytokine results (especially if enzyme-linked immunosorbent assay techniques are used), and the costs involved. 22 Recently, attention has been directed to the leukocyte cell surface antigens as diagnostic markers of sepsis. 23 Our goal in this prospective study was to enroll infants undergoing sepsis evaluation from the NICU and to measure the neutrophil CD64 expression in blood as an adjunct to our previously validated hematologic scoring system for detecting neonatal sepsis.
In the present study, neutrophil CD64 expression was increased significantly in the confirmed and clinical sepsis groups compared with the control group (P G 0.001). This was in accordance with the results of previous studies that suggested that neutrophil CD64 from both infected term and preterm infants was significantly up-regulated compared with healthy newborns. 5, 6, 23 As the diagnostic utilities (sensitivity, specificity, PPV, NPV) ultimately determine the usefulness of a clinical test, the one with a high sensitivity and NPV (approaching 100%) would be the most desirable in this situation because all genuinely infected cases are required to be identified and treated. The test should also have an acceptable specificity (980%) so that misclassification of noninfected cases and unnecessary use of antibiotics could be kept to a minimum. 10 Hence, we have presented the best cutoff values of CD64 from the ROC curve for assessment; the cutoff values of 45.8% and 46% for culture-proven sepsis and clinical sepsis, respectively, were considered optimal as they exhibited high sensitivities (both 96%) and specificities (both 100%), respectively. CD64 had the highest sensitivity (96%), specificity (100%), PPV (96.2%), and NPV (100%), with cutoff values of 45.8% and 46.0% in the confirmed and the clinical sepsis groups, respectively, compared with other hematologic parameters. This 6, 10 that reached high sensitivity (97%) and a moderate specificity (80%), respectively. On the other hand, Layseca-Espinosa et al 24 found that single determination of CD64 was associated with high sensitivity (96.8%) and a low specificity (25.8%), but when they performed repeated determinations of neutrophil CD64 (at 0, 8, 24 hours), they found a sustained increase in the percentage of CD64 cells and serial measurements for calculating the diagnostic utilities and therefore would be more representative.
In our study, total leukocytic count, differential leukocyte count, neutrophil ratios, and platelet count showed a limited accuracy with wide range of sensitivity and specificity, which could be due to a relatively long period necessary to become positive and the significant influence of nonspecific factors, and this goes with the results of Chirio and Loda. 1 It was not available to assess the accuracy of CRP as an inflammatory marker, because the quantitative CRP estimation was not performed in the patients enrolled in the current study.
In addition, we investigated the AUC of a combination of CD64/WBC, CD64/platelet count, CD64/ABC, and CD64/ ANC, where combined CD64 and ABC had the highest AUC in both the confirmed and the clinical sepsis groups. Bhandari 22 found that the CD64 index in combination with the absolute neutrophil count had the highest NPV (93%) for ruling out sepsis and 95% sensitivity for diagnosing sepsis.
A similar study was conducted by Streimish et al, 25 evaluating CD64 index utility in neonatal sepsis. For early-onset sepsis, the CD64 with a cut-point value of 2.38 had sensitivity, specificity, and NPV of 100%, 68%, and 100%, respectively. For late-onset sepsis, the respective values were 75%, 77%, and 96%. They concluded that neutrophil CD64 index can be incorporated as a valuable marker for excluding neonatal sepsis.
As expected, the hematologic profile of sepsis episodes was characterized by higher blood cell counts, absolute neutrophil and band counts, and immature/total neutrophil ratios but lower platelet counts; this goes with the results of Bhandari et al. 23 Advantages of using CD64 as a diagnostic marker are that (1) the flow cytometric analysis can be performed with minimal blood volume (50 HL of whole blood); (2) the result is variable within 4 hours after the specimen reaches the laboratory; (3) the measurement can be quantitative and thus enables comparison of results among different centers; (4) unlike cytokines, which are usually assayed in patches, the measurement of cell surface antigens is performed on an ad hoc basis; (5) the persistent expression of CD 64 for at least 24 hours gives the marker a wide diagnostic window; and (6) the very favorable diagnostic utilities in different studies render CD64 one of the best infection markers for the identification of early-and late-onset sepsis. 10 The points of weakness in our study may be (1) the use of semiquantitative method for measuring CD64, so we recommend using CD 64 index; (2) the qualitative method for measuring CRP; and (3) the relatively small number of cases studied. A potential limitation was interpreting the data of clinical sepsis because many of its signs are nonspecific, and others somewhat subjective.
In the view of the present study, use of neutrophil CD64 in addition to other markers as ABC may be of considerable value in diagnosis of neonatal sepsis; also, CD64 may be more useful in the setting of clinical sepsis versus confirmed sepsis to dictate a full course of antimicrobial treatment in the setting of a negative blood culture.
CONCLUSIONS
Neutrophil CD64 is a highly sensitive and specific marker for neonatal sepsis. Prospective studies incorporating CD64 into a sepsis scoring system are warranted. However, the important issues of cost and availability are required to be evaluated in routine clinical setting.
